GCTK (GlucoTrack) 5-Year Yield-on-Cost % : 0.00 (As of Dec. 13, 2024)

View and export this data going back to 2000. Start your Free Trial

What is GlucoTrack 5-Year Yield-on-Cost %?

GlucoTrack's yield on cost for the quarter that ended in Sep. 2024 was 0.00.

The historical rank and industry rank for GlucoTrack's 5-Year Yield-on-Cost % or its related term are showing as below:

GCTK's 5-Year Yield-on-Cost % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 2.05
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of GlucoTrack's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, GlucoTrack's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlucoTrack's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where GlucoTrack's 5-Year Yield-on-Cost % falls into.

GlucoTrack 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of GlucoTrack is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

GlucoTrack (NAS:GCTK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

GlucoTrack 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of GlucoTrack's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

GlucoTrack Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GlucoTrack Inc (NAS:GCTK) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

N/A

Address

301 Route 17 North, Suite 800, Rutherford, New Jersey, NJ, USA, 07070

Website

https://www.glucotrack.com

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

Executives

Drew Sycoff	director	C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017
James S Cardwell	officer: Chief Financial Officer	CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604
Erin Catherine Carter	director	301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070
Allen Danzig	director	301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070
Shimon D Rapps	director	C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017
David Podwalski	officer: Chief Commercial Officer	19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049
Michael Hauck	director	19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
John A Graham	director, officer: Chief Executive Officer	19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049
Sami Sassoun	officer: Chief Financial Officer	39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049
Philip Darivoff	director	1 FARMSTEAD ROAD, SHORT HILLS NJ 07078
Revan Schwartz	director	19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
Leslie Seff	director	PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487
Angela Strand Boydston	director	C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Eran Hertz	officer: Chief Financial Officer	C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100
Israel B. Ehrlich	director	C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100